- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 32.57M sh |
| Short Term Investments | Q1 2025 · Apr 5, 2025 | $99.93M |
| Short Term Investments | Q1 2025 · Dec 28, 2024 | $100.55M |
| Cash And Equivalents | Q1 2025 · Apr 5, 2025 | $324.88M |
| Cash And Equivalents | Q1 2025 · Dec 28, 2024 | $281.61M |
| Current Liabilities | Q1 2025 · Apr 5, 2025 | $119.72M |
| Current Liabilities | Q1 2025 · Dec 28, 2024 | $97.88M |
| Total Liabilities | Q1 2025 · Apr 5, 2025 | $161.08M |
| Total Liabilities | Q1 2025 · Dec 28, 2024 | $142.65M |
| Current Assets | Q1 2025 · Apr 5, 2025 | $618.67M |
| Current Assets | Q1 2025 · Dec 28, 2024 | $602.03M |
| Total Assets | Q1 2025 · Apr 5, 2025 | $1.23B |
| Total Assets | Q1 2025 · Dec 28, 2024 | $1.22B |
| Shares Diluted | Q1 2025 · Mar 30, 2024 | 31.91M sh |
| Capex | Q1 2025 · Mar 30, 2024 | $2.05M |
| Operating Cash Flow | Q1 2025 · Mar 30, 2024 | −$71.8M |
| Stockholders Equity | Q1 2025 · Mar 30, 2024 | $1.17B |
| Stockholders Equity | Q1 2025 · Dec 30, 2023 | $1.21B |
| Eps Diluted | Q1 2025 · Mar 30, 2024 | −$1.77 |
| Eps Basic | Q1 2025 · Mar 30, 2024 | −$1.77 |
| Sga Expense | Q1 2025 · Mar 30, 2024 | $33.55M |
| Rd Expense | Q1 2025 · Mar 30, 2024 | $80.65M |
| Operating Income | Q1 2025 · Mar 30, 2024 | −$59.13M |
| Gross Profit | Q1 2025 · Mar 30, 2024 | $55.07M |
| Cost Of Revenue | Q1 2025 · Mar 30, 2024 | $51.31M |
| Revenue | Q1 2025 · Mar 30, 2024 | $106.38M |